The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome

NCT05857891 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG: Human erythropoietin injection
DRUG: 0.9%NaCl

Sponsor

Second Affiliated Hospital of Wenzhou Medical University